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Go Red for Women
Prevalence of Asymptomatic Carotid Artery Stenosis
According to Age and Sex
Systematic Review and Metaregression Analysis
Marjolein de Weerd, MSc; Jacoba P. Greving, PhD; Anne W.F. de Jong, MSc;
Erik Buskens, MD, PhD; Michiel L. Bots, MD, PhD
Background and Purpose—In the discussion on the value of population-wide screening for asymptomatic carotid artery
stenosis (ACAS), reliable prevalence estimates are crucial. We set out to provide reliable age- and sex-specific
prevalence estimates of ACAS through a systematic literature review and meta-regression analysis.
Methods—We searched PubMed and EmBase until December 2007 for studies that reported the prevalence of ACAS in
a population free of symptomatic carotid artery disease. Data were extracted with use of a standardized form on
participants’ characteristics, assessment method, study quality, and prevalence estimates for moderate (50% stenosis)
and severe (70% stenosis) ACAS. Metaregression was used to investigate sources of heterogeneity.
Results—Forty studies fulfilled the inclusion criteria. There was considerable variation among studies with respect to
demographics, methods of grading stenosis, and stenosis cutoff point used. The pooled prevalence of moderate stenosis
was 4.2% (95% CI, 3.1% to 5.7%). Prevalence of moderate stenosis among people age 70 years was 4.8% (95% CI,
3.1% to 7.3%) in men and 2.2% (95% CI, 0.9% to 4.9%) in women. Among those 70 years, prevalence increased to
12.5% (95% CI, 7.4% to 20.3%) in men and to 6.9% (95% CI, 4.0% to 11.5%) in women. Metaregression showed that
both age and sex significantly affected the prevalence of moderate stenosis. No contribution of study size, publication
year, geographic region, assessment method, and study quality was found. The pooled prevalence of severe stenosis was
1.7% (95% CI, 0.7% to 3.9%).
Conclusions—Prevalence of moderate stenosis increases with age in both men and women, but men at all ages have the
higher prevalence estimates. The number of studies that allowed meaningful data synthesis of severe stenosis was
limited. (Stroke. 2009;40:1105-1113.)
Key Words: asymptomatic carotid artery stenosis  prevalence  systematic review  metaregression analysis
Stroke is the leading cause of death and hospitalization inboth men and women in nearly all European countries
and the third major cause of death in the United States.1,2
Carotid artery stenosis is 1 of the risk factors for stroke.3,4
Studies have reported an annual risk of stroke of 2% to 5%
for patients with severe asymptomatic carotid stenosis.4–7
Carotid endarterectomy is 1 of the most common vascular
surgery procedures, and it reduces the risk of stroke in
patients with symptomatic carotid stenosis.8,9 However, de-
spite the publication of several randomized, controlled trials
in asymptomatic patients,10,11 the role of carotid endarterec-
tomy and noninvasive screening is still debated,12–14 in part
because accurate estimates of the prevalence of carotid
stenosis in different risk groups are missing. This precludes
planning of effective screening and treatment of populations
at (high) risk of severe asymptomatic carotid stenosis who
might benefit from preventive surgery. We set out to provide
reliable age- and sex-specific prevalence estimates of asymp-
tomatic carotid artery stenosis through a systematic literature
review and a meta-analysis.
Methods
Search Strategy
We performed a PubMed and EmBase search to retrieve all pub-
lished articles reporting on the prevalence of asymptomatic carotid
artery stenosis from 1966 until December 2007. The following
keywords were used: carotid arter* diseas* (title/abstract), carotid
arter* stenos* (title/abstract), carotid stenos* (title/abstract), or
carotid arter* atheroscleros* (title/abstract) combined with preva-
lence (all fields), frequency (title/abstract), or occurrence (title/
abstract). A cross-reference check was performed to ascertain addi-
tional articles.
Study Eligibility
We reviewed the abstracts to identify studies that satisfied the
following predefined inclusion criteria. First, studies must have
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Table 1. Overview of Selected Articles









Chan16 1983 One friend control was selected by each diabetic;
Seattle, Wash
135 35–74 60 53
van Merode17 1985 Population sample Maastricht area,
The Netherlands
93 50–69 ND* 0
Josse18 1987 Patients referred for ultrasonic examination of
cervical arteries, Paris area, France
526 45–84 ND 58
Ramsey19 1987 Volunteers from church congregation, Illinois 102 50 ND 56
Colgan20 1988 Volunteers at health fairs, Illinois 348 24–91 61 60
Langsfeld21 1988 Volunteers at health fairs, Australia 153 40 56 48
Salonen22 1988 Population sample Kuopio area, Finland 412 42–60 51 0
Jungquist23 1991 Birth cohort of Malmö, Sweden 478 69 69 0
Bots24 1992 Subsample of the Rotterdam study,
The Netherlands
954 55 ND ND
O’Leary25 1992 Population sample Framingham, US 1189 66–93 ND ND
O’Leary26 1992 Subcohort of Cardiovascular Health Study, US 5116 65 ND 57
Prati27 1992 Population sample Friuli-Venezia Giulia region,
Italy
1348 18–99 ND 53
Puija28 1992 Elderly from retirement homes, Seattle, Wash 239 65–94 ND 76
Sutton-Tyrrell29 1993 Normotensive control subjects of SHEP,
Pittsburgh, Pa
187 60 ND 59
Willeit30 1993 Population sample Bruneck, Italy 909 40–79 ND 49
Fabris31 1994 Population sample, Turin, Italy 457 18–97 55 49
Lindgren32 1994 Control subjects, Lund, Sweden 59 51–95 72 49
Pascazio33 1994 Normotensive controls matched for age, sex, and
cardiovascular risk factors, Trieste, Italy
71 64–91 73 35
Aronow34 1995 Elderly in a long-term health care facility, US 1275 60–101 81 71
Auperin35 1996 Population sample Nantes, France 1279 59–71 65 59
Harer36 1996 Population sample Moscow, Russia 529 36–84 58 35
Beks37 1997 Normal glucose tolerance group of the Hoorn
Study, The Netherlands
287 50–74 63 48
Mannami38 1997 Population sample of Suita, Japan 1445 50–79 63 53
Martyn39 1998 Birth cohort of Sheffield, UK 181 70 68 33
Rodriguez-Saldana40 1998 Population sample of CUPA project, Mexico
City, Mexico
198 60 ND 72
Cheng41 1999 Healthy controls, Hong Kong, China 108 50 62 61
Meissner42 1999 Population sample Olmsted County, Minn 567 45 ND ND
Hillen43 2000 Healthy volunteers Berlin Ageing Study, Germany 225 70–100 80 41
(Continued)
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Table 1. Continued











– 50%, 50% 2 2 0 0.7 –
IDDM, unavailable lipid profiles 15%, 16–49%,
50–99%, 100%
1 2 3 5.4 –
Coronary and/or peripheral
vascular diseases, risk factors
for atherosclerosis









2 2 0 3.7 0.9
– 0–20%, 21–49%, 50%,
100%
2 2 0 1.3 0.7
– 20%, 20% 2 1 1 (3) – –
– 0–29%, 30–59%, 60% 1 2 2 (2, 3) – 3.1
– 0%, 1–15%, 16–49%,
50%
2 2 3 1.4 –
ND 0%, 1–24%, 25–49%,
50–74%, 75–100%
2 2 2 (1, 2) 7.6 2.4
– 0%, 1–24%, 25–49%,
50–74%, 75–99%, 100%
2 2 3 6.2 1.6
Stroke survivors 40%, 40% 2 2 3 – –
– 1–49%, 50–99%, 100% 2 2 1 (3) 4.6 –
Recent MI, stroke, heart failure,
PAD, TIA, contraindication to
study medication, systolic blood
pressure 160 mm Hg
50%, 50% 2 2 0 7.0 –
CEA, TIA/CVA, missing lab data 40%, 40–80%, 80% 2 1, 2 3 – 1.8
– 25%, 25–49%,
50–75%, 76–99%, 100%
2 1 3 3.9 0.9
Stroke, TIA 50%, 50–99%, 100%,
80–99%
2 2 2 (1, 2) 13.6 0
Not free from coronary or
cerebrovascular disease
20%, 20–49%, 50% 2 2 0 7.0 –
– 40%, 40–80%,
81–99%, 100%
2 2 0 – 3.5
CVA 0–20%, 20–40%, 60% 2 1 2 (1, 2) – –
ND 50, 50–60%, 70–80%,
90–95%, 100%
1 2 0 4.2 2.8
Diabetes mellitus, impaired
glucose tolerance
0–15%, 16–49%, 50% 2 2 2 (2, 3) 2.8 –
– 25%, 25–50%, 50% 2 1, 2 1(2) 4.4 –
– 0%, 1–30%, 31–50%,
50%
2 1 0 8.8 –
ND 50%, 50% 2 ? ? 6.1 –
– 0–29%, 30–69%,
70–99%, 100%
2 2 0 – 0
– 49%, 50–79%,
80–99%
2 2 2 (1, 2) 8.1 0.4
Immobility, need of help or
incontinence
50%, 51–75%, 75% 2 2 2 (2, 3) 15.1 4.0
(Continued)
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evaluated a population free of symptomatic carotid artery disease.
Conversely, studies on patients with clinically manifest vascular
disease or those at high risk for vascular events were excluded.
Studies with information on the prevalence of asymptomatic carotid
stenosis in the control groups of a clinical trial resembling the
general population were also included. Second, studies were required
to have reported sufficient detail to allow estimating the prevalence
of stenosis. Thus, studies with measurements of carotid intima-media
thickness of plaques only were not included. We included cross-
sectional and cohort study designs and articles in any language.
Studies were included only once if there were multiple publications
concerning the same study population.
Data Extraction
Two investigators (M.d.W. and A.W.F.d.J.) selected the studies to be
included in the review, extracted the data independently, and
cross-checked them, with disagreement resolved by discussion with
a third reviewer (either J.P.G. or M.L.B.). The following data were
extracted from each study: description of the population character-
istics (publication year, type of population, country, number of
included participants, age range, mean age, sex distribution), assess-
ment method, method of measurement of carotid stenosis, and
carotid stenosis prevalence estimates. Data were extracted with the
use of standardized data extractions forms specifically created for
this review and were subsequently entered into a database. Where
mean age was not stated, the population weighted mean or midpoint
of the range was derived. Because different cutoff points for stenosis
were used, we distinguished the following categories: moderate
stenosis (50%) and severe stenosis (70%).
Quality Assessment
Quality of all selected articles was assessed by 1 of the investigators
(J.P.G.) for the following attributes: representation of the general
population, appropriate recruitment of the population, and adequate
response rate. In prevalence studies, the participants selected ideally
should be representative of the general population. Methods of
achieving this may involve using population registries, inhabitants of
a defined area, and people registered with a general practice.
Participants attending health checkups may be biased and only cover
certain population groups. Recruitment was considered appropriate if
recruitment of participants was random or consecutive rather than
performed for convenience. A response rate of 50% or higher was
considered adequate.
Data Analysis
Prevalence estimates were, wherever possible, stratified by age and
sex for each study. Outcome measures were pooled across studies
with use of a random-effects model, which allows for heterogeneity
of effects between studies.15 To test our hypothesis concerning the
effect of age and sex, a metaregression model was built with
prevalence estimates of moderate stenosis as the dependent variable.
The covariates in this model were participants’ mean age, percentage
Table 1. Continued









Mannami44 2000 Population sample, Ikawa, Japan 249 50–69 60 0
Mathiesen45 2001 Population sample Tromsø Study, Norway 6420 25–84 ND 53
Su46 2001 Normotensive adults from the Chin-San
Community Cardiovascular cohort, Taiwan
270 35 64 58
Lernfelt47 2002 Birth cohort of Gothenburg, Sweden 142 78 78 50
Mineva48 2002 Population sample of the city of Stara Zogara,
Bulgaria
500 50–79 ND 60
Luedemann49 2002 Population sample of northeast region of Germany 1632 45–70 58 53
Wang50 2002 Offspring and spouses of offspring of Framingham
Heart cohort, US
3173 25–90 55 52
Rosvall51 2002 Subcohort of Malmö Diet and Cancer study,
Sweden
4208 46–68 ND 57
Alkaabi52 2003 Matched controls of rheumatology outpatient
clinics, Dundee, UK
40 36–73 55 50
Horner53 2005 Subsample from the Austrian Stroke Prevention
Study
500 50–70 ND ND
Takahashi54 2005 Matched controls of the HIMEDIC Imaging Center,
Japan
605 54 63 34
Hupp55 2007 Vascular screening program in Annapolis, Md 11 636 40–95 65 59
IDDM indicates insulin-dependent diabetes mellitus; MI, myocardial infarction; PAD, peripheral artery disease; TIA, transient ischemic attack; CEA, carotic
endarterectomy; and CVA, cerebrovascular accident. Because the majority of studies did not report the method of measurement (ie, NASCET or ECST method) of
stenosis, a column with this information was not added. When the method of measurement was reported, the NASCET method was used.
*Not documented.
†1Doppler, 2duplex.
‡1Lumen diameter reduction, 2peak systolic velocity method.
§1Representation of the general population, 2appropriate recruitment of the population (random or consecutive), 3adequate response rate (50%).
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of women, study size, publication year, geographic region, assess-
ment method (Doppler versus duplex), and several quality indicators.
Publication bias was examined visually with a funnel plot of study
precision against effect size and statistically by Egger’s test. A
deficiency in the base of the funnel with asymmetry indicates the
presence of possible publication bias from unpublished small studies.
Statistical analyses were performed with SAS (version 9.1) and
STATA (version 8.0).
Results
Figure 1 shows the consecutive steps that were followed to
identify the appropriate studies. We identified 40 studies that
fulfilled all inclusion criteria.16–55 Table 1 summarizes the
characteristics of these studies. One of these publications was
in Spanish,40 and the remaining 39 were in English. Three
studies26,45,55 examined 5000 individuals and contributed
almost 50% of the total number of individuals. There was a
considerable variation among studies with respect to demo-
graphics (age and sex distribution), methods of grading
stenosis, and the stenosis cutoff point used. Study quality
assessment revealed deficiencies in many areas of methodol-
ogy. Seven studies met all 3 quality criteria, 10 studies met 2
criteria, 7 met 1 criterion, and the remaining 15 studies met no
quality criterion (Table 1).
Moderate Carotid Artery Stenosis
From 29 studies, we obtained data on 22 636 individuals,
including 959 persons with moderate carotid artery stenosis
(50%).16–18,20,21,24–26,28,29,31–33,36–40,42–49,52–54 Prevalence of
moderate stenosis ranged from 0% to 22.5%, with a pooled
random-effects prevalence estimate of 4.2% (95% CI,
3.1% to 5.7%; Figure 2). Restricting our analysis to only
population-based studies17,24 –26,31,32,42,45,53 resulted in a
similar pooled prevalence estimate of 4.1% (95% CI, 2.4%
to 6.8%).
Table 1. Continued











– 25%, 25–49%, 50% 2 1, 2 0 9.6 –
Persons from previous dietary
trial
35%, 35% 2 2 3 3.4 0.9
– 50%, 50% 2 2 2 (2, 3) 1.5 –
People who lived in nursing
homes
50%, 51–75%, 75% 2 2 1 (3) 22.5 4.9




2 2 1 (2) 6.4 0.4
Without cerebrovascular
symptoms
History of MI or stroke,
complete data
50%, 50% 2 2 1 (3) 2.0 –
– 25%, 25%, 2 2 2 (1, 3) – –
Technical problems with duplex
scan, missing lab data,
homemakers
15%, 15% 2 1 2 (1, 2) – –




2 1 0 0 0
Not free from previous
cerebrovascular attacks
50%, 50–70%, 90% 2 ? 1 (1) 1.2 0.4
History of neurologic disorder,
abnormal neurology
manifestation
25%, 25–49%, 50% 2 1 0 2.0 –







potentially eligible titles 
identified and screened 
246 
full text publications 
retrieved for detailed evaluation 
Excluded:
− Studies on patients with 
clinically manifest vascular 
disease, and patients at 
high-risk for vascular events 
− Studies with measurements 
of carotid intima media 
thickness or plaques only. 
− Publications without abstract 
− Duplicate publications 
 
40 






Figure 1. Results of search strategy.
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Eight studies provided prevalence estimates stratified by
age and sex.17,18,26,38,40,43,44,47 Prevalence estimates were het-
erogeneous even within age and sex subgroups (Figure 3).
Prevalence of moderate stenosis was higher in men than in
women 70 years, being, on average 4.8% (95% CI, 3.1% to
7.3%) in men and 2.2% (95% CI, 0.9% to 4.9%) in women.
In those age 70, prevalence estimates were higher, being,
on average, 12.5% (95% CI, 7.4% to 20.3%) in men and 6.9%
(95% CI, 4.0% to 11.5%) in women. One included study47
examined a birth cohort at age 78 and had an exceptionally
high prevalence estimate (22.5%; range in other studies, 0%
to 15.1%). Exclusion of this study altered the results in those
age70 to 10.7% (95% CI, 6.6% to 16.9%) in men and 5.8%
(95% CI, 3.7% to 9.1%) in women.
Metaregression analysis showed that both age and sex had
a significant influence on the prevalence of moderate steno-
sis. There was an estimated increase in prevalence of mod-
erate stenosis for older age and male sex (Table 2). The
estimated between-study variance was reduced from 0.20 to
0.10. There was no significant effect of study size, publica-
tion year, geographic region, assessment method, and study
quality on moderate stenosis prevalence estimates (Table 2).
Examination of the funnel plot (not shown) demonstrated that
there was no asymmetry for studies on prevalence of moder-
ate carotid artery stenosis (Egger’s test P0.438).
Severe Carotid Artery Stenosis
For the analysis of severe carotid artery stenosis (70%), only 4
studies, totaling 6518 individuals, provided data.36,41,45,47 Over-
all, the prevalence of severe stenosis ranged from 0% to 4.9%,
with a pooled random-effects prevalence estimate of 1.7% (95%
CI, 0.7% to 3.9%). Stratified analysis and metaregression anal-
ysis were not attempted for prevalence of severe stenosis
analysis given the paucity of studies.
Discussion
We conducted a systematic review of studies addressing the
prevalence of moderate and severe carotid artery stenosis and
a metaregression analysis to understand the reasons for
estimate variability. Our findings show that the prevalence of
moderate stenosis increases with age in both men and women,
but that men at all ages have the highest prevalence estimates.
Different age and sex distribution across studies explained
half of the heterogeneity in prevalence estimates. The number
of studies that allowed meaningful data synthesis of severe
stenosis was limited.
Information on the prevalence of asymptomatic carotid
stenosis may provide insight into the planning and allocation
of funds for screening methods to detect patients who may
benefit from carotid endarterectomy. Although there are
sufficient data to provide reliable age- and sex-specific
prevalence estimates of moderate stenosis, there are limited
data on prevalence estimates of severe stenosis available in
the literature. At present, there is considerable variation
among studies with respect to cutoff point used for severe
Figure 2. Prevalence of moderate asymptomatic carotid artery
stenosis (50% stenosis). Bars indicate 95% CI on the
proportion.
Figure 3. Prevalence of moderate asymptomatic carotid artery
stenosis (50% stenosis) stratified according to age and sex
wherever possible. Bars indicate 95% CI on the proportion.
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stenosis (70%, 75%, and 80% stenosis). Moreover, the
method of measurement used, ie, NASCET or ECST,
which was not always reported, may also have influenced
the estimates. As a result, no reliable age- and sex-specific
prevalence estimates for severe stenosis could be provided,
while probably only asymptomatic patients with severe stenosis
are at high enough risk to justify carotid endarterectomy.10,11,14
To resolve this lack of accurate age- and sex-specific prevalence
estimates of severe stenosis, we might ask original investigators
for stratified analyses for the degree of stenosis of interest.
However, in that case, we might as well ask for the individual
patient data. The latter would allow recoding of variables, more
flexible analyses, and more advanced modeling techniques.
We observed that moderate stenosis was more prevalent
among men than women, and there was an increasing prevalence
with age, which confirms previous findings.26,29–31,39,45 Given
that carotid endarterectomy also appeared to be more beneficial
in men than women,13,14 this might imply that screening for
asymptomatic carotid stenosis might be more worthwhile among
men with reasonable life expectancy than among women.
However, treatment choice requires a comparison of acute
treatment-related risks and future stroke risk, and only a well-
designed decision analysis can gain the best possible insight in
the balance of risks and benefits. Such analysis can also
determine whether screening would be effective in the entire
population or in subgroups according to age or sex only.
Therefore, further research is required to identify those
individuals with asymptomatic stenosis who might derive
the most benefit from preventive treatment.
This study has several limitations. First, the stratified
prevalence estimates may have been influenced by the rela-
tively small number of studies that provided age- and sex-
specific data. Another limitation concerns nonresponse within
the included studies. As nonresponse increases with age and
asymptomatic carotid stenosis is more prevalent in older
patients, the overall prevalence estimates may have been
underestimated. Third, the studies included in this review
used different methods to determine the degree of stenosis, ie,
duplex or Doppler alone. Duplex screening has been shown to
be an accurate method for assessing carotid stenosis56 and is
the most frequently used method nowadays. Doppler screen-
ing alone has been shown to be less accurate than duplex
screening and tends to underestimate the degree of stenosis.
Metaregression showed that the overall prevalence estimates
of moderate stenosis, however, did not essentially differ
between studies that used the duplex assessment method and
those that used Doppler alone. In addition, we reviewed
whether the included studies reported the method of measure-
ment of stenosis (ie, NASCET or ECST method), because it
has been shown that the NASCET method results in lower
estimates of the degree of stenosis compared with the ECST
method.57 Unfortunately, only a few studies provided details
about the method of measurement used. Because of the lack
of information about which method of measurement was
used, we were unable to convert stenosis values to 1 uniform
method. Surprisingly, metaregression showed that quality
features did not significantly add to the variation in preva-
lence estimates of moderate stenosis. Our quality scoring
method may, however, not have entirely captured all meth-
odologic aspects. Alternatively, the seemingly considerable
number of studies (N29) may still have been too small to
yield sufficient statistical power for conducting metaregression
analyses. We think, however, that factors such as average age
and sex may be much stronger determinants, ie, may have
overruled methodologic quality of the studies.
In conclusion, we noted that good stratified prevalence
estimations are difficult to extract from the literature. Collab-
orative efforts with pooled analysis of individual patient data
are needed to estimate the prevalence of asymptomatic
carotid stenosis in subgroups more accurately. Such data can
then also be used to explore whether screening and treatment
Table 2. Effect of Covariates on Prevalence of Moderate
Carotid Artery Stenosis (Random Effects Models)




Age 0.067 (0.017) 0.001
Female (%) 0.012 (0.009) 0.219
Study characteristics
Study size
1000 or more Reference
500–999 0.285 (0.449) 0.526
500 0.033 (0.393) 0.399
Publication year
2000 or later Reference
1990–1999 0.298 (0.339) 0.380
Before 1990 0.592 (0.482) 0.220
Geographic region
America Reference
Europe 0.247 (0.364) 0.497








Appropriate recruitment 0.256 (0.333) 0.443
Adequate response rate 0.022 (0.339) 0.949




Age 0.080 (0.017) 0.001
Female (%) 0.022 (0.007) 0.003
*Parameter estimates (SEs) are presented on a logit scale. The estimated
prevalence of moderate stenosis, given particular values of the covariates,
can be derived from the regression equation. For example, the estimated
logit (prevalence) for women at age 60 is given by7.3480.080600.022
1004.71, which corresponds to a prevalence of moderate stenosis of
exp(4.71)0.9%.
†High-quality studies had 2 of more of the 3 high-quality criteria. See
Methods for details.
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of carotid artery stenosis in asymptomatic patients would be
worthwhile.
Source of Funding
This study was supported by an unconditional grant from the
Netherlands Organization for Health Research and Development
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